$PFE: Interesting juncture here...
Diupdate
Pfizer has a curious setup where both an uptrend or down trend could trigger next, depending on which extreme of last week's range is crossed first.
As per the chart, you can go long on a break of last week's high or short on a break of last week's low, with stops as depicted on chart. Targets may be subject to updates, if price action forms larger consolidation patterns in the direction of the trade and the initial entry isn't stopped. Odds of the trade working and making some progress in the next week are big if the trade is triggered, you could secure some gains by Friday close, if the target or the stop aren't hit, or just exit the trade altogether to revisit it next week, if continuation occurs.
Best of luck!
Ivan Labrie.
As per the chart, you can go long on a break of last week's high or short on a break of last week's low, with stops as depicted on chart. Targets may be subject to updates, if price action forms larger consolidation patterns in the direction of the trade and the initial entry isn't stopped. Odds of the trade working and making some progress in the next week are big if the trade is triggered, you could secure some gains by Friday close, if the target or the stop aren't hit, or just exit the trade altogether to revisit it next week, if continuation occurs.
Best of luck!
Ivan Labrie.
Catatan
Short might get filled soon, nothing yet...Catatan
Order dibatalkan
Cancel orders but set alerts under $50.70, the daily mode is now lower, so we need a confirmed break down from this area, still likely to happen under last week's low.Trading ditutup secara manual
Bearish side won this one...Catatan
Time expires on the 24th, we might see price start to base soon.
Catatan
Time expires today, can start forming a reversal setup.
🔒Want to dive deeper? Check out my paid services below🔒
ivanlabrie.substack.com/
ivanlabrie.substack.com/
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.